|By PR Newswire||
|April 8, 2014 06:07 AM EDT||
CRANFORD, N.J., April 8, 2014 /PRNewswire/ -- The arrival of new oral drugs for treatment of hepatitis C will dramatically shift the landscape of therapy from being physician-driven to patient-led, raising questions about best practices for adherence. A White Paper published by Atlantis Healthcare offers a roadmap of the new therapeutic environment for pharma industry, healthcare providers and organized customers, including clinical insights, non-adherence predictors and proven interventions to improve adherence.
"Adherence is critical and we need to be on top of that," said Professor David Goldberg, leader of Health Protection Scotland's hepatitis C program and contributor to the latest report from the Adherence Research Summarized™ series. "The new drugs are expensive and there is the possibility that the virus could become resistant if adherence is sub-optimal, so we will need to support people to take the medication."
Hepatitis C is a virus carried in the blood affecting 170 million people worldwide. In the US, more than 3.2 million people live with chronic hepatitis C, with 16,000 new cases diagnosed each year. According to the report, while therapy offers the possibility of cure, the majority of people living with hepatitis C do not receive treatment. For those who do start treatment, good outcomes are dependent on a high level of adherence.
Current treatment for hepatitis C involves weekly interferon injections combined with oral drugs. Side effects, include fatigue, headache and depression, are the most common reason for discontinuing treatment. The new drugs are in simple pill form, bypassing the need for injections or frequent hospital visits, and offer shorter duration of treatment and improved effectiveness.
"With the new therapies coming on line, much of the demand for the treatment will come from the patients," said Dr. Goldberg. "They will hear it's much easier to take, more effective, has fewer side effects and can be taken without disrupting one's work."
According to the report, the greater patient responsibility in hepatitis C therapy will present challenges to the healthcare community, especially when supporting hepatitis C patients who have other chronic conditions. Research reviewed indicates that simple patient-led interventions, including personalized nursing support and supplemental patient education from a health care provider other than the physician, can help increase treatment adherence.
For more information and to download the report, visit http://atlantishealthcare.com/hepatitis-c-white-paper/
SOURCE Atlantis Healthcare
While DevOps promises a better and tighter integration among an organization’s development and operation teams and transforms an application life cycle into a continual deployment, Chef and Azure together provides a speedy, cost-effective and highly scalable vehicle for realizing the business values of this transformation. In his session at @DevOpsSummit at 19th Cloud Expo, Yung Chou, a Technology Evangelist at Microsoft, will present a unique opportunity to witness how Chef and Azure work tog...
Sep. 29, 2016 04:45 AM EDT Reads: 1,793
Sep. 29, 2016 04:30 AM EDT Reads: 4,672
Sep. 29, 2016 04:00 AM EDT Reads: 1,805
Sep. 29, 2016 04:00 AM EDT Reads: 1,207
Sep. 29, 2016 03:45 AM EDT Reads: 4,818
Sep. 29, 2016 03:30 AM EDT Reads: 3,029
Sep. 29, 2016 03:30 AM EDT Reads: 1,375
Sep. 29, 2016 03:15 AM EDT Reads: 3,575
Sep. 29, 2016 03:15 AM EDT Reads: 1,905
Sep. 29, 2016 03:00 AM EDT Reads: 1,868
Sep. 29, 2016 02:45 AM EDT Reads: 1,718
Sep. 29, 2016 02:30 AM EDT Reads: 520
Sep. 29, 2016 02:30 AM EDT Reads: 2,174
Sep. 29, 2016 02:00 AM EDT Reads: 1,592
SYS-CON Events announced today that Numerex Corp, a leading provider of managed enterprise solutions enabling the Internet of Things (IoT), will exhibit at the 19th International Cloud Expo | @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Numerex Corp. (NASDAQ:NMRX) is a leading provider of managed enterprise solutions enabling the Internet of Things (IoT). The Company's solutions produce new revenue streams or create operating...
Sep. 29, 2016 01:45 AM EDT Reads: 2,057